Is Betahistine Effective in the Treatment of Ménière's Disease?

Holmes, Sean; Lalwani, Anil K.; Mankekar, Gauri

doi:10.1002/lary.29535

Cited by 1 publication

(1 citation statement)

References 6 publications

(5 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Betahistine, a structural analog of histamine, is a weak H 1 R agonist and a strong H 3 R antagonist [64,80]. It is used to treat Ménière's disease, particularly in central Europe [78].…”

Section: Clinical Applicationmentioning

confidence: 99%

Histamine and Its Receptors in the Mammalian Inner Ear: A Scoping Review

2023

View full text Add to dashboard Cite

Background: Histamine is a widely distributed biogenic amine with multiple biological functions mediated by specific receptors that determine the local effects of histamine. This review aims to summarize the published findings on the expression and functional roles of histamine receptors in the inner ear and to identify potential research hotspots and gaps. Methods: A search of the electronic databases PubMed, Web of Science, and OVID EMBASE was performed using the keywords histamine, cochlea*, and inner ear. Of the 181 studies identified, 18 eligible publications were included in the full-text analysis. Results: All four types of histamine receptors were identified in the mammalian inner ear. The functional studies of histamine in the inner ear were mainly in vitro. Clinical evidence suggests that histamine and its receptors may play a role in Ménière’s disease, but the exact mechanism is not fully understood. The effects of histamine on hearing development remain unclear. Conclusions: Existing studies have successfully determined the expression of all four histamine receptors in the mammalian inner ear. However, further functional studies are needed to explore the potential of histamine receptors as targets for the treatment of hearing and balance disorders.

show abstract

“…Betahistine, a structural analog of histamine, is a weak H 1 R agonist and a strong H 3 R antagonist [64,80]. It is used to treat Ménière's disease, particularly in central Europe [78].…”

Section: Clinical Applicationmentioning

confidence: 99%